8-K
Current Report
Vistagen Therapeutics, Inc. Filed Acc 0001437749-23-025509
Material agreement · Regulation FD disclosure · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading vtgn20230908_8k.htm…